Back
Email UpdatesNew JerseyState Snapshot for Chronic Kidney Disease
In this comparison, the NHQDR measures for New Jersey for the most recent data year and the baseline year are compared to the average of all States.
Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.
| Measure | Recent Year | Recent Rate | Recent Performance | Baseline Year | Baseline Rate | Baseline Performance |
|---|---|---|---|---|---|---|
| Adult hemodialysis patients with adequate dialysis - (Kt/V) 1.2 or higher | 2018 | 97.7 | Better than Average | 2015 | 95.2 | Better than Average |
| Ratio of observed deaths to expected deaths among hemodialysis patients | 2018 | 0.9 | Better than Average | 2000 | 1.1 | Worse than Average |
| Hemodialysis patients whose hemoglobin level is less than 10 g/dL | 2018 | 20.4 | Better than Average | 2015 | 21.2 | Worse than Average |
| Dialysis patients who were registered on a waiting list for transplantation | 2017 | 18.3 | Better than Average | 2000 | 19.3 | Better than Average |
| Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure | 2014 | 14.6 | Better than Average | 2000 | 16.8 | Worse than Average |
| Measure | Recent Year | Recent Rate | Recent Performance | Baseline Year | Baseline Rate | Baseline Performance |
|---|---|---|---|---|---|---|
| Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access | 2017 | 66.3 | Average | 2012 | 64.4 | Better than Average |
| Measure | Recent Year | Recent Rate | Recent Performance | Baseline Year | Baseline Rate | Baseline Performance |
|---|---|---|---|---|---|---|
| Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy | 2017 | 33.0 | Worse than Average | 2012 | 31.8 | Average |